Suchergebnisse

Risk assessment of suicidal behavior is a time-consuming but notoriously inaccurate activity formental health services globally. In the last 50 years a large number of tools have been designed for suicide risk assessment, and tested in a wide variety of populations, but studies show that these tools suffer fromlow positive predictive values.More recently, advances in research fields such as machine learning and natural language processing applied on large datasets have shown promising results for health care, and may enable an important shift in advancing precision medicine. In this conceptual review, we discuss established risk assessment tools and examples of novel data-driven approaches that have been used for identification of suicidal behavior and risk. We provide a perspective on the strengths and weaknesses of these applications to mental health-related data, and suggest research directions to enable improvement in clinical practice ; This manuscript was written as a result of a workshop that was held at the Institute of Psychiatry, Psychology and Neuroscience, King's College London, financially supported by the European Science Foundation (ESF) Research Networking Programme Evaluating Information Access Systems: http://elias-network.eu/. SV is supported by the Swedish Research Council (2015-00359) and the Marie Skłodowska Curie Actions, Cofund, Project INCA 600398. EB-G is partially supported by grants from Instituto de Salud Carlos III (ISCIII PI13/02200; PI16/01852), Delegación del Gobierno para el Plan Nacional de Drogas (20151073); American Foundation for Suicide Prevention (AFSP) (LSRG- 1-005-16). NW is supported by the UCLH NIHR Biomedical Research Centre. DN is supported by The Alan Turing Institute under the EPSRC grant EP/N510129/1, with an Alan Turing Institute Fellowship (TU/A/000006). RP has received support from a Medical Research Council (MRC) Health Data Research UK Fellowship (MR/S003118/1) and a Starter Grant for Clinical Lecturers (SGL015/1020) supported by the Academy of Medical Sciences, The Wellcome Trust, MRC, British Heart Foundation, Arthritis Research UK, the Royal College of Physicians and Diabetes UK. DL is supported by the UK Medical Research Council under grant MR/N028244/2 and the King's Centre for Military Health Research. JD is supported by a Medical Research Council (MRC) Clinical Research Training Fellowship (MR/L017105/1). RD is funded by a Clinician Scientist Fellowship (research project e-HOST-IT) from the Health Foundation in partnership with the Academy of Medical Sciences